INTRODUCTION
============

During the critical period, considered beginning at the childhood until thirty years old, brain is particularly influenced by social and psychological interactions between an individual and his environment. The resulting interplay strongly affects the development of the central nervous system^[@r1]^. Obviously, the majority of mood disorders are caused by a failure in one or many of these natural processing. As a consequence of these brain disorders, suicidal behaviours appear during emotional development^[@r2]-[@r4]^. A healthy lifestyle ensures a healthy brain and an excellent shield skill against central nervous system failure and cognitive disabilities^[@r5],[@r6]^.

Epidemiologic data reported that, central nervous connections are modulated by the game of stimuli-response, play continuously by both nature and human^[@r7]^, and these modulations increase the risk to develop neurodegenerative diseases and mood diseases, and also suicidal tendencies. Young adults (between eighteen years old until thirty years old) are because of that, more expose to the risk to develop anxiety and psychiatric disorders^[@r1],[@r8]^. Until now, no final therapy exists for mood disorders, but prevention of risk factors and promotions of good lifestyle are important because, suicide and brain disorders are not easy to handle.

Physical activity and sleep are potential tools able to decrease suicidal behaviours for young adults\' population (YA), compared with midlife and elderly adults^[@r9]^. Many other studies focused on risk factors like sociodemographic pattern of economic fluctuations, usage of drugs or family history of suicidal attempts, previous traumatic events in life; known to increase mental disorders and associated psychopathologies^[@r10],[@r11]^. But to our knowledge, just a hand of studies showed an accurate relation between combinations of non-psychological and non-environmental factors in suicidal behaviours for YA^[@r12]-[@r14]^. The current research seeks to exhibit incidence on suicidal behaviours of the complex combination of the following factors: sleep parameters, mood disorders parameters and general health status of our subjects.

METHODS
=======

Ethics committee
----------------

The current research was approved beforehand, by the ethic committee of research of the faculty of arts and science of the University of Montreal, Canada. All our subjects were volunteers and signed a consenting form.

Population\'s Criteria
----------------------

Sociodemographic and clinical raw data of age, drugs associated with suicidal behaviours, gender, education, family history disorders, memory deficiency and cognitive complaints were collected with a self-made questionnaire named Mental Health Profile of Etindele (MHPE). This scale was used in previous published studies^[@r15],[@r16]^. Current and history of medications were classified as medications of musculoskeletal, neurological, respiratory or cardiovascular disease. Other treatments were grouped into antibiotics, anxiolytics, protein drinks, acupuncture, hypnosis, sleeping pills and anti-inflammatory. McNair scale was calculated using the short version of 15 items. Subjects aged more than 40 years old, enabled to complete experiments and speaking other languages than English and French were excluded from analysis.

Suicide and Sleep Parameters
----------------------------

Sleep impairments and quality were authenticated with seven items; sleep duration, use of sleeping pills, history of medication, duration of medication, beginning of sleeping disorders, sleep quality ranged from 1 (very bad) to 5 (very well) and the difficulty of falling asleep from 1 (None) to 4 (very difficult). 1545 respondents were assessed in subjective suicidal behaviour using our questionnaire. It includes two different subsections related to anxiety and depression. Both were analysed together as a single scale, this last was our suicidal behaviour\'s test. The self-report for assessing suicidal behaviour included 20 items scored from 0 (never or not applicable) to 4 (very often). We determined so the suicidal tendencies over the global score ranging from 0 (no tendency) to 60 (high suicidal tendency). Scores more than or equal to 25 points were considered indicative of high suicidal behaviour, with a maximum score of 60 points.

Statistical Analysis
--------------------

The distribution of suicidal measures was normal, and tested with the Kolmogorov-Smirnov\'s test. To analyse McNair test answers, scores were converted to a dichotomous variable, individuals with a score fewer than 15 were scored «No cognitive complaints» vs whose score is more than or equal to 15 were scored «Presence of cognitive complaints». Spearman rank was employed to analyse the relationship between the continuous variables general health, stress, dependency, well-being and McNair score. Mann-Whitney\'s non-parametric test for independent samples was used to compare McNair score as a continuous variable between two groups. Kruskal Wallis test was used for comparing McNair score for more than two groups. Logistic regression was applied to study the relationships between McNair\'s scale as a dependent variable, and sleep parameters as independent variables.

Statistical tests used an alpha of 0.05 as a level of significance. Odds ratios were calculated for sleep parameters. Data analysis was executed using SPSS Statistics-version 23 for windows 10, 64 bits (IBM Corporation, Armonk, NY, USA). ICC values 0.70 and above were accepted as a high level of correlation. Test-retest and internal consistency analyses were performed to identify the reliability of the questionnaire MHPE. Cronbach alpha value was considered excellent for above 0.80. Intraclass Correlation Coefficient (ICC) (95% confidence interval) was used for test-retest value and Cronbach alpha was used for internal consistency measure.

Construct validity of the MHPE was assessed by factor analysis and convergent validity of the questionnaire was determined to use the Pearson correlation coefficient method after total scores obtained from McNair scale, Hopital Anxiety and Depression Scale (HADS), and Columbia Suicide Severity Rating (C-SSRS). For the Pearson correlation coefficient, 0.87 to 1.00, 0.81 to 1.00, 0.41 to 0.60, 0.21 to 0.40, and 0.10 to 0.20 were considered to be respectively: excellent, very good, good, poor, and no correlation.

RESULTS
=======

1545 subjects were used in the study. The response to the questionnaire was maximum. 78% of the sample was aged between 18 and 24 years, a significant proportion. One of the properties of the present research is, compared to few previous studies, a big representative population was recruited to study the impact of clinical and lifestyle factors in suicidal behaviour in adults, mainly younger adults. Women represented 64.3% of the sample. Most of the respondents were undergraduates (71%). [Table 1](#t1){ref-type="table"} represented socio-demographic and clinical parameters of the total cohort. Cronbach alpha value was found 0.894, showing that this questionnaire has high internal consistency. The results of test-retest analysis was varying between 0.883 and 0.941, which shows that test-retest results are highly correlated. Pearson correlation coefficients of the MHPE Questionnaire with HADS Questionnaire was calculated 0.762 and it was found with C-SSRS is 0.774. These results showed that the MHPE Questionnaire is very well correlated with C-SSRS Questionnaire and HADS Scale.

###### 

Relationships between Suicidal Behavior score and demographic and clinical characteristics

  Characteristics                                                                                Mean ±SD Or n (%)   Suicidal behavior score Mean±SD   Statistics
  ---------------------------------------------------------------------------------------------- ------------------- --------------------------------- ------------
  Demographics                                                                                                                                          
  *Age*                                                                                                                                                0.01
  18 - 24                                                                                        1205 (78%)          17.3 ± 1.21                        
  24 - 30                                                                                        278 (18%)           15.45 ± 0.39                       
  30 - 36                                                                                        62 (4%)                                                
  *Gender*                                                                                                                                              
  Male                                                                                           552 (35.7%)         14.6 ± 0.209                      0.000
  Female                                                                                         993 (64.3%)         14.75 ± 0.219                      
  *Level of education*                                                                                                                                 *0.000*
  First cycle                                                                                    1097 (71%)          18.68 ± 1.23                       
  Secondary cycle                                                                                309 (20%)           23.60 ± 0.88                       
  Third cycle                                                                                    116 (7.5%)          15.30 ± 0.458                      
  Else (certificat. AEC. DEP. microprogramme)                                                    23 (1.5%)                                              
  *medication history*                                                                                                                                  
  Cognitive or memory impairment drugs                                                                                                                 0.735
  Yes                                                                                            74 (4.8%)           13 ± 0.504                         
  No                                                                                             1471 (95.2%)        14.30 ± 0.191                      
  Family history of neurological. musculoskeletal. respiratory or cardiovascular disease (1-6)                                                         0.000
  Cardiovascular disease                                                                         588(38.1%)          14.08±0.5                          
  Musculoskeletal disease                                                                        74(4.8%)            12±0.76                            
  Neurologic disease                                                                             221(14.3%)          27±1.91                            
  Respiratory disease                                                                            37(2.4%)            20                                 
  Other                                                                                          221(14.3%)          11.8±0.3                           
  None                                                                                           405(26.2%)          14.05±1.28                         
  Family\'s history for cognitive or memory impairments (1-6)                                                                                          0.000
  Memory deficiency                                                                              109(7.1%)           18.33±0.491                        
  Attention deficit disorders                                                                    147(9.5%)           23.75±0.221                        
  Alzheimer                                                                                      330(21.4%)          9±0.233                            
  Cognitive impairments                                                                          809(52.4%)          14.86±0.258                        
  Other                                                                                          0                   0                                  
  None                                                                                           147(9.5%)           13±0.226                           
  *Medication. current*                                                                                                                                 
  Medication of neurological. musculoskeletal. respiratory or cardiovascular disease (1-6)                                                             0.000
  Cardiovascular disease                                                                         37(2.4%)            16                                 
  Musculoskeletal disease                                                                        37(2.4%)            21                                 
  Neurologic disease                                                                             74(4.8%)            19.5±1.55                          
  Respiratory disease                                                                            110(7.1%)           13±0.92                            
  Other                                                                                          110(7.1%)           14±1.25                            
  None                                                                                           1177(76.2%)         14.34±0.222                        
  Depression                                                                                                                                           0.000
  Normal                                                                                         1375 (89%)          14.62±0.19                         
  Moderate                                                                                       110(7.1%)           25±1.08                            
  Mild                                                                                           37(2.4%)            24±0.5                             
  Severe                                                                                         37(2.4%)            38±1.036                           
  Anxiety                                                                                                                                              0.000
  Normal                                                                                         819(53%)            15.5±0.35                          
  Moderate                                                                                       556(36%)            16.86±0.76                         
  Mild                                                                                           164(10.6%)          15.29±0.75                         
  Severe                                                                                         6(0.4%)             21±1.8                             
  General health score                                                                           9.71± 0.45                                            0.380
  Well-being score                                                                               10.88 ± 1.38                                          0.000
  Stress score                                                                                   37.81±7.87                                            0.419
  Dependency score                                                                               10.64±1.04                                            0.008

Suicidal Behaviour and Clinical Parameters
------------------------------------------

In the analysis of family history\'s disease, 41% (n=633) suffered from cardiovascular disease and 17.7% (n=273) suffered from neurologic disease. 52.4% (n=809) of them, have family members with suicidal behaviours and 35% (n=541) suffered from Alzheimer. 2.4% (n=37) of respondents were treated from cardiovascular disease, 4% (n=62) suffered from musculoskeletal disease, 6.5% (n=100) used medication for neurologic disease and 9% (n=139) has a breath impairment. All clinical parameters were associated with suicidal behaviour (*p*\<0.0001, Kruskal Wallis test) except for the usage of drugs or memory impairment (*p*=0.735, U Mann-Whitney\'s test).

The analysis of depression and anxiety showed that 89% (n=1375) of the participants have a depression but 36% (n=556) has a moderate anxiety. The average well-being score was 14±0.38 (SD) with a good correlation with McNair score (*p*\<0.0001, spearman rank). The mean dependency score was 13.45±1.84 (SD), based on Spearman rank it\'s associated with McNair score (*p*=0.0004). However, there was no correlation between general health score, stress score and McNair score (*p*=0.348, *p*=0.395 respectively with Spearman rank test).

Association Between Suicidal Behaviour and Sleep Parameters
-----------------------------------------------------------

[Table 2](#t2){ref-type="table"} exhibits a good association between suicidal behaviour and sleep parameters except for the beginning of sleep disturbances (*p*=0,364, U Mann Whitney test). [Table 3](#t3){ref-type="table"} showed that this association would persist even when we considered all sleep parameters as independent variables and McNair score as dependent variable. The logistic regression was employed on uncorrelated variables to identify the best indicators for suicidal behaviour score.

###### 

Relationships between sleep parameters and suicidal behavior

  Sleep parameters                                Suicidal behaviour's score Mean±SD   Kruskal ou mann whitney   p-value
  --------------------------------- ------------- ------------------------------------ ------------------------- ----------
  Sleep duration                    4h            26±0.93                              85.11                     0.000
  5h                                21.5±1.06                                                                    
  6h                                15.25±0.82                                                                   
  7h                                13.06±0.26                                                                   
  8h                                12.97±1.05                                                                   
  More than 8h                      15.63±0.30                                                                   
  Sleeping pills                    Yes           28                                   9.35                      0.000
  No                                13.25±0.86                                                                   
  Medication                        None          13.54±0.23                           277.88                    0.000
  antibiotics                       12±0.16                                                                      
  antidepressants                   38±0.22                                                                      
  vitamins or energetic drinks      9.92±1.5                                                                     
  Acupuncture or hypnosis           16±1.23                                                                      
  Anxiolytics or sleeping pills     26 ±0.75                                                                     
  anti-inflammatory                 11±0.88                                                                      
  Duration of medication            None          13.52±0.23                           139.8                     0.000
  Less than one month               17.5±0.59                                                                    
  1 month - 6 months                14.25±0.54                                                                   
  6 months - 1 year                 26                                                                           
  More than one year                13.29±0.34                                                                   
  Beginning of sleep disturbances   None          14.23±.19                            -0.775                    0.364 NS
  Before                            14.29±0.474                                                                  
  Sleep quality                     Very bad      34±1.06                              100.07                    0.000
  Bad                               18±0.91                                                                      
  Mild                              14.75±0.29                                                                   
  Well                              10.32±0.48                                                                   
  Very well                         5.4±0.74                                                                     
  Difficulty falling a sleep        None          7±0.6                                211.95                    0.000
  little                            12±1                                                                         
  Difficult                         12.60±0.48                                                                   
  Very difficult                    18.87±0.11                                                                   

###### 

Logistic regression analysis of the association between subjective suicidal behavior and sleep complaints

                               β         SE        OR (95% C.I.)            p-value
  ---------------------------- --------- --------- ------------------------ ---------
  Sleep duration                                                             
      4h                       -1.439    0.395     0.237(0.109/0.514)       0.000
      5h                       -2.667    0.352     0.069(0.035/0.138)       0.000
      6h                       -0.803    0.243     0.448(0.278/0.720)       0.001
      7h                       -1.017    0.200     0.362(0.244/0.535)       0.000
  Duration of medication                                                     
      None                     0.440     0.212     1 .552(1.024/2.353)      0.038
      Less than month          3.709     0.458     40.807(16.630/100.134)   0.000
      1 month - 6 months       2.359     0.316     10.578(5.693/19.653)     0.000
      6 months - 1 year        20.759    7105.18   1133096220.169           0.998
  Sleep quality                                                              
      Very bad                 -20.052   7105.18   0                        0.998
      Bad                      0.382     0.430     0                        0.374
      Mild                     0.955     0.276     2.598(1.512/4.462)       0.001
      Well                     -0.085    0.244     0                        0.728
      Very well                                                              
  Difficulty falling a sleep                                                 
      None                     1.080     0.370     2.945(1.427/6.077)       0.003
      little                   0.153     0.384     0                        0.690
      Difficult                -1.731    0.395     0.177(0.082/0.384)       0.000
      Very difficult                                                         

Multicollinearity was detected between the parameters: sleeping pills, medication, and beginning of sleep disturbances. Four variables were included: sleep duration, duration of medication, sleep quality and difficulty falling asleep. Logistic regression analysis revealed that 44.8% of the variance in suicidal behaviours was explained by sleep duration, duration of medication, sleep quality and difficulty falling asleep ([Table 3](#t3){ref-type="table"}).

The model was significant (*p*\<0.05).

The variable sleep quality was the least significant factor in the model (Wald statistic= 29.06) and duration of medication the most significant (Wald statistic= 106.57). Sleep time (Wald statistic= 64.24, *p*-value \<0.0001), duration of medication of one month or between one month and six months (*p*-value \<0.000 *vs*. 6 months-1 year, *p*=0.928), no difficulty of falling asleep (Wald statistic= 79, *p*-value=0.001) or have a difficulty to fall asleep (*p*-value \<0.000 vs a little difficulty to fall asleep, *p*-value=0.436), mild subjective sleep satisfaction (*p*-value \<0.000) were associated with suicidal problems. The odds ratios were ranged from 42 for the duration of medication (less than one month) to 0.058 for sleep time (5 hours).

DISCUSSION
==========

Effect of sleep in our knowledge was not recorded continuously, and our objective is to elaborate an accurate model to predict suicidal behaviours on young adult population. Many studies were focused on environmental factors such as poverty and lake of social insurance, which could negatively increase the risk of suicidal attempts. But to our understanding, there are fewer proofs of links between simultaneous actions of the pair physical activity of participants and their duration of sleep, on the suicide in general, and suicidal behaviour in particular^[@r17]-[@r19]^.

It has been established in the last decade physical activity is a way to reduce stress and cognitive decline process^[@r20],[@r21]^, while a good quality of sleep and an appropriate duration of sleep perfectly ensures brain maturation and good mental health^[@r22]-[@r27]^. Issue is adequate data for young adult\'s suicidal behaviours are not precise until now, and our findings suggest the idea of a positive interplay of lifestyle and sleep in general; on suicidal behaviour. People with less than eight hours of study and at least a moderate anxiety, has a bad global score on McNair tests and all his dimensions.

This result is also the same, in items related to suicidal behaviour. This longitudinal research confirms the hypothesis that during learning process; neuronal memory is more configured by the environment. It is may be possible that suicidal behaviours start sooner as current epidemiological and clinical literature reported. The originality is the sensitive model of prediction we are developing currently, as this research is the first step. We are able to predict the suicidal behaviour with our protocol, even with people without a medical diagnostic. According to our observations, a regular evaluation of suicidal behaviour while controlling sleep parameters (duration and quality) and cognitive complaints may lead to a sensitive model of detection.

We think, it was a weakness in the present research, not to follow changes in these parameters, and record continuously evolution of suicidal behaviours, during many weeks after the study. We also consider our population excluded people with physical limitations, like blind and autistic individuals, whose will probably improve the quality of our sample.

Each of the independent variables has been already studied alone or in association, to see their impact on suicidal aetiology, psychiatric disorders and/or neurodegenerative diseases^[@r28]-[@r30]^. But another originality of the present study, compared to previous studies above with the same design; our MHPE scale evaluated more accurately correlation between McNair test\'s score and the multiple variables: age, sex, duration of sleep, suicidal behaviour, and explores more deeply simultaneous effect of depression, anxiety, global health, family suicide attempt\'s history of participants.

CONCLUSIONS
===========

A healthy mental function and appropriate quality of sleep including an efficient duration, contribute both to a better prevention of suicidal tendency for young adults until midlife. Young adults and midlife samples for both men and women have almost the same level of stress but, suicidal parameters of men are more affected by this combination compared to women. Age is also a main factor because the majority of our sample was aged between eighteen and thirty, and the best score for cognitive subsection and even suicidal behaviour test; was obtained by people over thirty years old. These findings suggest that, monitoring the cognitive function and sleep clinical parameters for a young adult population, may help to improve detection or at least evaluation of suicidal tendencies.
